Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

2.40
Delayed Data
As of Feb 23
 +0.04 / +1.69%
Today’s Change
1.20
Today|||52-Week Range
6.24
+45.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$33.2M

Company Description

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy. The company was founded by Paul F. Truex on September 9, 2004 and is headquartered in Hayward, CA.

Contact Information

Anthera Pharmaceuticals, Inc.
25801 Industrial Boulevard
Hayward California 94545
P:(510) 856-5600
Investor Relations:
151085656005621

Employees

Shareholders

Mutual fund holders5.03%
Other institutional38.36%
Individual stakeholders0.37%

Top Executives

John Craig ThompsonPresident, CEO & Executive Director
May LiuCAO, Senior VP-Finance & Administration
William R. ShanahanChief Medical Officer
Renee MartinSenior Vice President-Medical Science
Patrick M. MurphySenior Vice President-Manufacturing